Skip to main content

Advertisement

ADVERTISEMENT

Volume 9 - Issue 8 - August 2012

Insights

Interview
08/02/2012
During pregnancy, the risk of blood clots in the legs or blood clots going to the lungs increases 4-5 fold. It is more frequently observed during the third trimester.
During pregnancy, the risk of blood clots in the legs or blood clots going to the lungs increases 4-5 fold. It is more frequently observed during the third trimester.
During pregnancy, the risk of...
08/02/2012
Vascular Disease Management

Feature

Case Report
08/02/2012
A 41-year-old female presented with post-thrombotic syndrome following diagnosis of deep vein thrombosis, treated with anticoagulation and placement of an IVC filter. Further work-up revealed chronic left iliac vein occlusion secondary to...
A 41-year-old female presented with post-thrombotic syndrome following diagnosis of deep vein thrombosis, treated with anticoagulation and placement of an IVC filter. Further work-up revealed chronic left iliac vein occlusion secondary to...
A 41-year-old female presented...
08/02/2012
Vascular Disease Management
Case Report
08/01/2012
An aneurysm developing in hypertrophied pancreaticoduodenal artery associated with a median arcuate ligament compressing the celiac trunk is a relatively rare entity. We present 2 such cases that we managed recently.
An aneurysm developing in hypertrophied pancreaticoduodenal artery associated with a median arcuate ligament compressing the celiac trunk is a relatively rare entity. We present 2 such cases that we managed recently.
An aneurysm developing in...
08/01/2012
Vascular Disease Management

Column

Clinical Editor's Corner
08/01/2012
On April 4, 2012, the FDA cleared Cook’s AAA fenestrated stent-graft for commercialization in the U.S. This is a customized design that must be constructed to the anatomical specifications of an individual patient.
On April 4, 2012, the FDA cleared Cook’s AAA fenestrated stent-graft for commercialization in the U.S. This is a customized design that must be constructed to the anatomical specifications of an individual patient.
On April 4, 2012, the FDA...
08/01/2012
Vascular Disease Management

Advertisement

Advertisement

Advertisement